Pablo (@Pablomc1996) header
Pablo (@Pablomc1996) profile picture

Rheumatologist at HU General Valencia | PhD at @ucv_svm | MD at @ucv_svm | Reumatología Hospital General Universitario de Valencia (España)

Valencia, Spain
Joined January 2012
Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)Photo by Pablo (@Pablomc1996)
Pablo retweeted
🏆 One of the EMEUNET EULAR Top 10 abstracts is now published in ARD! 📄 Congrats to Milena Bond and co-authors on their contribution to Polymyalgia Rheumatica! 🎉 @eular_org #eularEMEUNET #EULAR #ARD #PolymyalgiaRheumatica #Rheumatology #EULARTop10
5
14
617
NEW RESEARCH—Efficacy and safety of upadacitinib in Takayasu arteritis (SELECT-TAK): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial thelancet.com/journals/lanrh…
32
3
75
5,481
Recordando el ACR 2026 pasado el jet lag, muchos reumatólogos jovenes dejando el liston muy alto y seniors aportando tanto, encantador encuentro con los colegas latinoamericanos, Orgullo de sociedad @SEReumatologia
1
5
34
1,439
#IgG4-RD ▶️New guidelines: Fewer steroids, earlier targeted treatment. Initial prednisone ≤30–40 mg/day; GC monotherapy ≤3 months. Steroid-sparing induction for most; B-cell-directed therapy reduces relapse (1b/A). Maintenance only in selected patients. thelancet.com/action/showPdf…
13
29
1,706
Back home, so happy 😃 I could be part of #ACR26 and keen to keep studying and learning Rheumatology. Over the next few days, I’ll catch up on talks I missed and share what I find interesting 🧐 I hope to be at ACR 2027 !!!
2
21
771
📢 Ya disponible la tercera y última entrega de los vídeos resúmenes de #ACReview26, que los revisores/as han ido preparando día a día. ¡Gracias por vuestra gran labor durante este #ACR26! 🙌 Accede aquí a todo el contenido dividido por áreas: ➡️acr-review.ser.es/
7
8
249
IgG4-RD ➡️ Rare, heterogeneous disease (4 phenotypes; male:female 3:1). Exclude malignancy, infection and inflammatory mimics before diagnosis. Cancer risk remains uncertain. Limit cumulative GC exposure; consider baseline whole-body imaging case by case. #ACR26
1
47
102
4,210
IgG4 Guidelines👇
🔥Hot off the press for #ACR26 🔥 The @IgG4ward foundation guidelines on the treatment of IgG4-related disease thelancet.com/journals/lanrh… Free to read on lancet.com
30
107
6,712
Pablo retweeted
What incredible energy in Orlando! 🌟 Great seeing the EMEUNET community come together at #ACR26 to exchange ideas, discuss priorities, and shape our future. Thanks to everyone who joined! #eularEMEUNET #Rheumatology #ACR2026 congress
4
23
851
Momentos épicos de la Legislatura.
6
824
9
12,324
143,982
Pablo retweeted
“The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease” are now published in The Lancet Rheumatology. 52 physicians, 10 patients and caregivers, six continents, 28 Statements. Full story and article link at: igg4ward.org/resources/the-i… #IgG4RD #RareDisease
4
7
294
So happy to present two of our studies at #ACR26 today! 🔹 Abstract 1123: meta-analysis of JAK inhibitors in Takayasu arteritis. 🔹Abstract 1168: systematic review of mepolizumab and benralizumab in EGPA.
5
5
52
1,553
Dermatomyositis ▶️ Periungual erythema and cuticular dystrophy may accompany nailfold microangiopathy. Unpublished study (53 DM vs 41 SLE): capillary dilation 81.1% vs 31.7%, dropout 67.9% vs 24.4%, capillary-bed disruption 77.4% vs 17.1% (all p<0.001). #ACR26
6
9
451
Mil gracias por el apoyo!
#ACR26 Trabajos españoles sobre vasculitis 🙌🙌. No dejéis de pasad a verlos @SEReumatologia
1
6
272
#ACR26 Trabajos españoles sobre vasculitis 🙌🙌. No dejéis de pasad a verlos @SEReumatologia
1
2
1
8
831
Pablo retweeted
Poetry in slow motion 👌 #F1 #BrazilGP
59
1,462
77
12,516
398,373
Pablo retweeted
🎥 Meet José Miguel Sequí-Sabater, one of your #EMEUNET Social Media Correspondents at #ACR26! ✨ Follow @drjsequirheum for congress highlights, key insights and the latest in rheumatology from Orlando. 🇺🇸 📲 Stay tuned ! #eularEMEUNET #ACR26 congress
6
13
617
🦋 Exciting lupus research ahead at #ACR2026!
🦋 What's hot in #LupusResearch at #ACR2026? 🔬 Explore the abstracts selected by Lupus Hub, including our team's ReBioLup study (Abstract 1862)! 🔗 Read more: parodislab.com/2026/11/acr-2… #Rheumatology
1
2
148